Swift Molecular Diagnostics Overview
- Status
- Private
- Employees
- 5
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
Swift Molecular Diagnostics General Information
Description
Developer of a genetic fingerprint detection technology. The company develops a technology that enables diagnostic devices to detect genetic and antibiotic resistance and facilitate treatment of bacterial infections.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
- Department of Genetics
- University of Cambridge, Downing Street
- Cambridge CB2 3EH
- England, United Kingdom
Swift Molecular Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Swift Molecular Diagnostics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Benjamin Shaw | Chief Executive Officer | ||
| Gustavo Cerda-Moya Ph.D | Inventor & Chief Technology Officer |
Swift Molecular Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSwift Molecular Diagnostics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accelerate Cambridge | Accelerator/Incubator | 000 0000 | 000000 0 |